COST ANALYSIS OF PRIMARY CARE ANAESTHETICS IN INDIAN MARKET: GENERIC VERSUS BRANDED
Keywords:Anesthetics, Primary care, Essential drug, Drug price control order
Objective: The aim of the study was to study the degree of compliance of primary care anesthesia dispensing companies in following the pricing norms set by drug price control order 2013 (DPCO).
Methods: This is an observational and analytical study where the dosage, strength, and ceiling price of the generic primary care anesthetics were obtained from the National pharmaceutical pricing authority updated price list 2022 and similar data of their various counterpart brands were obtained from www.medguideindia.com. Thereafter, comparisons of their ceiling price along with the brands cost range, cost ratio, and percent cost variation were sought.
Results: Our study retrieved 150 brands of total 11 injectable/topical primary care anesthetics available in India of which 39.33% brands had prices more than DPCO recommended ceiling price. Maximum price violation (90%) was noticed with brands of Inj. Midazolam 5 mg/mL. The maximum cost variation and cost ratio was seen with brands of Inj. Lignocaine 1–2% (10 mg/mL) of 148.37% and 149.37, respectively.
Conclusion: The adjuvant sedative hypnotic, Midazolam which is often used to supplement the action of primary sedative hypnotics in inducing general anesthesia, violating price ceiling is a matter of great concern as it would adversely impact the primary patient care; the most basic level of health care which almost whole population needs at some time or the other. Similarly adding to the misery of the common man is the maximum cost ratio and percent cost variation of the local anesthetic, Inj. Lignocaine 1–2% as it continues its prominence as the most widely used local anesthetic agent.
Notification and Report on National List of Essential Medicines; 2022. Available from: https://www.mohfw.gov.in/sites/default/files/ notificationandreportonnational listofessential medicinesofindia2022. pdf [Last accessed on 2022 Oct 30].
Primary Health Care in India; 2022. Available from: https://www. who.int/india/health-topics/primary-health-care [Last accessed on 2022 Oct 30].
NPPA and DPCO. Available from: https://www.journalsofindia.com/ nppa-and-dpco [Last accessed on 2022 Oct 20].
NPPA Updated Price List as on 18/04/2022. Vol. 2022(S).O; 149. Gazette Notification. Available from: https://www.drive.google. com/file/d/1i7xfbSkiM2fNh4AbEvpWh2pMxITmbWYy/view [Last accessed on Oct 30 2022].
India MG; 2010. Available from: https://www.medguideindia.info/ showgenerics.php [Last accessed on 2022 Oct 20].
Ray A, Najmi A, Khandelwal G, Sadasivam B, Cost A. A cost variation analysis of drugs available in the Indian market for the management of thromboembolic disorders. Cureus 2020;12:e7964. doi: 10.7759/ cureus.7964, PMID 32523821
Craven R. Ketamine. Anaesthesia 2007;62:48-53. doi: 10.1111/j.1365- 2044.2007.05298.x, PMID 17937714
Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin 2016;37:865-72. doi: 10.1038/aps.2016.5, PMID 27018176
Ketamine Hydrochloride (Ketamine HCl): Uses, Dosage, Side Effects, Interactions, Warning; 2022. Available from: https://www.rxlist.com/ ketamine-hydrochloride-drug.htm#description [Last accessed on 2022 Oct 30].
Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ. Midazolam: Pharmacology and uses. Anesthesiology 1985;62:310-24. doi: 10.1097/00000542-198503000-00017, PMID 3156545
Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2008;3:CD001905. doi: 10.1002/14651858.CD001905.pub2, PMID 18646081
Walker M. Status epilepticus: An evidence-based guide. BMJ 2005;331:673-7. doi: 10.1136/bmj.331.7518.673, PMID 16179702
Midazolam 2mg/ml, Solution for Injection/Infusion Summary of Product Characteristics (SmPC); 2022. Available from: https://www.medicines.org.uk/emc/product/6418/smpc#gref [Last accessed on 2022 Oct 30].
Midazolam 5mg/ml, Solution for Injection/Infusion Summary of Product Characteristics (SmPC); 2022. Available from: https://www. medicines.org.uk/emc/product/6420/smpc#gref [Last accessed on 2022 Oct 30].
Balakrishnan K, Ebenezer V, Dakir A, Kumar S, Prakash D. Bupivacaine versus lignocaine as the choice of local anesthetic agent for impacted third molar surgery a review. J Pharm Bioallied Sci 2015;7:S230-3. doi: 10.4103/0975-7406.155921, PMID 26015720
Sobczak Ł, Goryński K. Pharmacological aspects of over-the-counter opioid drugs misuse. Molecules 2020;25:3905. doi: 10.3390/ molecules25173905, PMID 32867117
Mukherjee K. A cost analysis of the Jan Aushadhi scheme in India. Int J Health Policy Manag 2017;6:253-6. doi: 10.15171/ijhpm.2017.02,PMID 28812812
Jadhav NB, Bhosale MS, Adhav CV. Cost analysis study of oral antidiabetic drugs available in Indian market. Int J Med Res Health Sci 2013;2:63-9.
Kumar R, Manu C, Singh DJ, Lakhani P, Tutu S, Dixit R. The extent of price variation amongst branded antihypertensive drugs and its association with number of pharmaceutical companies. Int J Res Med Sci 2015;3:2800-6. doi: 10.18203/2320-6012.ijrms20150689
Chawan VS, Badwane SV, Gawand KV, Chhaya MU. Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market. Int J Res Med Sci 2016;4:2398-401. doi: 10.18203/2320-6012.ijrms20161821
Maxwell S. Rational prescribing: The principles of drug selection. Clin Med (Lond) 2009;9:481-5. doi: 10.7861/clinmedicine.9-5-481, PMID 19886113
How to Cite
Copyright (c) 2022 Preeti Kanawjia, Anupama Gupta, MADHU CHAUDHARY
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.